Mark Laws is a postdoctoral research associate in the Rahman laboratory in the Institute of Pharmaceutical Science, King’s College London. He graduated from Durham University in 2015 with an MSci in Biology and Chemistry and joined the Rahman group the same year to study for a PhD in Medicinal Chemistry. His PhD project involved the synthesis of novel efflux-resistant fluoroquinolone antibacterial compounds. Awarded his doctorate in 2020, his current research project involves the investigation and development of new antitubercular drugs.